Inflection Biosciences Announces Publication of Positive Data for IBL-202 in DLBCL.
Dublin, Ireland, July 30, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
top of page
News
Press Releases
- May 12, 2020
Inflection Biosciences Announces Participation at Upcoming Industry Conferences.
Dublin, Ireland, May 12th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Feb 19, 2020
Inflection Biosciences Announces Appointment of Shaun McNulty, Ph.D., as Chief Scientific Officer.
Dublin, Ireland, February 19th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
- Feb 6, 2020
Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer
(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the...
- Jan 31, 2020
Inflection Biosciences to present at BIO CEO & Investor Conference 2020.
Dublin, Ireland, January 31, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
bottom of page